Roles of membrane-type matrix metalloproteinase-1 in tumor invasion and metastasis

Cancer Science

Volumn 96, Issue 4, 2005, Pages 212-217

  Sato, Hiroshi ^a   Takino, Takahisa ^a   Miyamori, Hisashi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; AMYLOID PRECURSOR PROTEIN; COLLAGEN TYPE 1; CONNECTIVE TISSUE GROWTH FACTOR; ENZYME PRECURSOR; GELATINASE A; HERMES ANTIGEN; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; LAMININ; LIGAND; LUMICAN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN KISS 1; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SYNDECAN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

CANCER INVASION; CANCER SURVIVAL; CELL SURFACE; DRUG TARGETING; ENZYME ACTIVITY; ENZYME SUBSTRATE; EXTRACELLULAR MATRIX; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVIEW;

ANIMALS; CLINICAL TRIALS; HUMANS; METALLOENDOPEPTIDASES; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS;

EID: 20044387216     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2005.00039.x     Document Type: Review

References (41)

1. Woessner JFJ. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991; 5: 2145-54.
2. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993; 9: 541-73.
3. Seiki M, Yana I. Roles of pericellular proteolysis by membrane type-1 matrix metalloproteinase in cancer invasion and angiogenesis. Cancer Sci 2003; 94: 569-74.
4. Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990; 6: 121-5.
5. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994; 370: 61-5.
6. Hotary KB, Allen ED, Brooks PC, Datta NS, Long MW, Weiss SJ. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 2003; 114: 33-45.
7. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases structure, function, and biochemistry. Circ Res 2003; 92: 827-39.
8. Brown PD, Bloxidge RE, Stuart NSA, Gatter KC, Carmichael J. Association between expression of activated 72-Kilodaloton gelatinase and tumor spread in non-small-cell lung carcinoma. J Natl Cancer Inst 1993; 85: 574-8.
9. Azzam HS, Arand G, Lippman ME, Thompson EW. Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 activation. J Natl Cancer Inst 1993; 85: 1758-64.
10. Nomura H, Sato H, Seiki M, Mai M, Okada Y. Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res 1995; 55: 3263-6.
11. Ueno H, Nakamura H, Inoue M, Imai K, Noguchi M, Sato H, Seiki M, Okada Y. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinoma. Cancer Res 1997; 57: 2055-60.
12. Tokuraku M, Sato H, Murakami S, Okada Y, Watanabe Y, Seiki M. Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int J Cancer 1995; 64: 355-9.
13. Holmbeck K, Bianco P, Caterina J, Yamada S, Kromer M, Kuznetsov SA, Mankani M, Robey PG, Poole AR, Pidoux I, Ward JM, Birkedal-Hansen H. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 1999; 99: 81-92.
14. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y. Membrane-type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997; 272: 2446-51.
15. Koshikawa N, Giannelli G, Cirulli V, Miyazaki K, Vito Quaranta V. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol 2000; 148: 615-24.
16. Li Y, Aoki T, Mori Y, Ahmad M, Miyamori H, Takino T, Sato H. Cleavage of lumican by membrane-type matrix metalloproteinase-1 abrogates this proteoglycan-mediated suppression of tumor cell colony formation in soft agar. Cancer Res 2004; 64: 7058-64.
17. Ratnikov BI, Rozanov DV, Postnova TI, Baciu PG, Zhang H, DiScipio RG, Chestukhina GG, Smith JW, Deryugina EI, Strongin AY. An alternative processing of integrin αv subunit in tumor cells by membrane type-1 matrix metalloproteinase. J Biol Chem 2002; 277: 7377-85.
18. Belkin AM, Akimov SS, Zaritskayai LS, Ratnikov BI, Deryugina EI, Strongin AY. Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. J Biol Chem 2001; 276: 18415-22.
19. Kajita M, Itoh Y, Chiba T, Mori H, Okada A, Kinoh H, Seiki M. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 2001; 153: 893-904.
20. Endo K, Takino T, Miyamori H, Kinsen H, Yoshizaki T, Furukawa M, Sato H. Cleavage of syndecan-1 by membrane-type matrix metalloproteinase-1 stimulates cell migration. J Biol Chem 2003; 278: 40764-70.
21. Takino T, Koshikawa N, Miyamori H, Tanaka M, Sasaki T, Okada Y, Seiki M, Sato H. Cleavage of metastasis suppressor gene product KiSS-1 protein/metastin by matrix metalloproteinases. Oncogene 2003; 22: 4617-26.
22. Tam EM, Morrison CJ, Wu YI, Stack MS, Overall CM. Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. Proc Natl Acad Sci USA 2004; 101: 6917-22.
23. Higashi S, Miyazaki M. Identification of a region of β-amyloid precursor protein essential for its gelatinase a inhibitory activity. J Biol Chem 2003; 278: 14020-8.
24. Montesano R, Matsumoto K, Nakamura T, Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 1991; 67: 901-8.
25. Kadono Y, Shibahara K, Namiki M, Watanabe Y, Seiki M, Sato H. Membrane type 1-matrix metalloproteinase (MT1-MMP) is involved in the formation of hepatocyte growth factor/scatter factor-induced branching tubules in Madin-Darby Canine Kidney (MDCK) epithelial cells. Biochem Biophys Res Commun 1998; 251: 681-7.
26. Kadono K, Okada Y, Namiki M, Seiki M, Sato H. Transformation of epithelial MDCK cells with pp60v-src induces expression of membrane-type 1-matrix metalloproteinase and the invasiveness. Cancer Res 1998; 58: 2240-4.
27. Takino T, Miyamori H, Watanabe Y, Yoshioka K, Sato H. Membrane-Type 1 Matrix Metalloproteinase Regulates Collagen-dependent Mitogen-Activated Protein/Extracellular Signal-Related Kinase Activation and Cell Migration. Cancer Res 2004; 64: 1044-9.
28. Kolettas E, Rosenberger RF. Suppression of decorin expression and partial induction of anchorage-independent growth by the v-src oncogene in human fibroblasts. Eur J Biochem 1998; 254: 266-74.
29. Yoshioka N, Inoue H, Nakanishi K, Oka K, Yutsudo M, Yamashita A, Hakura A, Nojima. H. Isolation of transformation suppressor genes by cDNA subtraction: lumican suppresses transformation induced by v-src, and v-K-ras. J Virol 2000; 74: 1008-13.
30. Leygue E, Snell L, Dotzlaw H, Troup S, Hiller-Hitchcock T, Murphy LC, Roughley PJ, Watson PH. Lumican and decorin are differentially expressed in human breast carcinoma. J Pathol 2000; 192: 313-20.
31. Nakamura H, Suenaga N, Taniwaki K, Matsuki H, Yonezawa K, Fujii M, Okada Y, Seiki M. Constitutive and induced CD44 shedding by ADAM-like proteases and membrane-type 1 matrix metalloproteinase. Cancer Res 2004; 64: 876-82.
32. Nagano O, Saya H. Mechanism and biological significance of CD44 cleavage. Cancer Sci 2004; 95: 930-5.
33. Bernfield M, Kokenyesi R, Kato M, Hinkes MT, Spring J, Gallo RL, Lose EJ. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol 1992; 8: 365-93.
34. Inki P, Jalkanen M. The role of syndecan-1 in malignancies. Ann Med 1996; 28: 63-7.
35. Rapraeger AC. Molecular interactions of syndecans during development. Semin Cell Dev Biol 2001; 12: 107-16.
36. Dobra K, Andang M, Syrokou A, Karamanos NK, Hjerpe A. Differentiation of mesothelioma cells is influenced by the expression of proteoglycans. Exp Cell Res 2000; 258: 12-22.
37. Li Q, Park PW, Wilson CL, Parks WC. Matrilysin shedding of syndecan-1 shedding of syndecan-1 regulates chemokine mobiblization and transepithelial efflux of neutrophils in acute lung injury. Cell 2002; 111: 635-46.
38. Joensuu H, Anttonen A, Eriksson M, Makitaro R, Alfthan H, Kinnula V, Leppa S. Cancer Res 2002; 62: 5210-7.
39. Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, Welch DR. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Institute 1996; 88: 1731-1737. Erratum in J Natl Cancer Institute 1997; 89: 1549.
40. Lee JH, Welch DR. Identification of highly expressed genes in metastasis-suppressed chromosome 6/human malignant melanoma hybrid cells using subtractive hybridization and differential display. Int J Cancer 1997; 71: 1035-44.
41. Ohtaki T, Shintani Y, Honda S, Matsumoto H, Hori A, Kanehashi K, Terao Y, Kumano S, Takatsu Y, Masuda Y, Ishibashi Y, Watanabe T, Asada M, Yamada T, Suenaga M, Kitada C, Usuki S, Kurokawa T, Onda H, Nishimura O, Fujino M. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 2001; 411: 613-7.